Medistim ASA (OSL:MEDI)
Norway
· Delayed Price · Currency is NOK 233.00
+3.00 (1.30%)
Apr 29, 2026, 1:46 PM CET
Medistim ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,207 | 4,735 | 2,738 | 3,912 | 4,216 | 6,693 | Upgrade
|
| Market Cap Growth | 36.73% | 72.95% | -30.01% | -7.22% | -37.01% | 47.10% | Upgrade
|
| Enterprise Value | 4,045 | 4,599 | 2,618 | 3,790 | 4,111 | 6,629 | Upgrade
|
| Last Close Price | 230.00 | 259.00 | 144.18 | 201.40 | 214.03 | 335.63 | Upgrade
|
| PE Ratio | 26.41 | 29.74 | 26.37 | 37.68 | 36.99 | 73.64 | Upgrade
|
| Forward PE | 27.09 | 29.10 | 25.34 | 33.80 | 39.94 | 61.56 | Upgrade
|
| PS Ratio | 6.01 | 6.77 | 4.87 | 7.51 | 8.67 | 16.02 | Upgrade
|
| PB Ratio | 8.98 | 10.11 | 6.27 | 9.83 | 11.47 | 21.87 | Upgrade
|
| P/TBV Ratio | 11.01 | 12.39 | 7.28 | 11.10 | 12.71 | 24.26 | Upgrade
|
| P/FCF Ratio | 23.17 | 26.08 | 19.98 | 38.05 | 40.45 | 55.79 | Upgrade
|
| P/OCF Ratio | 22.49 | 25.31 | 19.13 | 32.82 | 37.15 | 52.55 | Upgrade
|
| EV/Sales Ratio | 5.78 | 6.57 | 4.65 | 7.27 | 8.45 | 15.87 | Upgrade
|
| EV/EBITDA Ratio | 19.06 | 22.61 | 19.02 | 25.83 | 26.11 | 52.09 | Upgrade
|
| EV/EBIT Ratio | 20.61 | 23.44 | 19.97 | 28.83 | 29.10 | 59.73 | Upgrade
|
| EV/FCF Ratio | 22.27 | 25.33 | 19.11 | 36.86 | 39.43 | 55.26 | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.11 | 0.08 | 0.04 | 0.05 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.23 | 0.23 | 0.23 | 0.11 | 0.10 | 0.18 | Upgrade
|
| Debt / FCF Ratio | 0.27 | 0.27 | 0.25 | 0.17 | 0.16 | 0.20 | Upgrade
|
| Net Debt / Equity Ratio | -0.35 | -0.35 | -0.33 | -0.34 | -0.37 | -0.34 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.80 | -0.80 | -1.05 | -0.93 | -0.86 | -0.83 | Upgrade
|
| Net Debt / FCF Ratio | -0.90 | -0.90 | -1.06 | -1.32 | -1.30 | -0.88 | Upgrade
|
| Asset Turnover | 1.13 | 1.13 | 1.04 | 1.05 | 1.10 | 1.12 | Upgrade
|
| Inventory Turnover | 0.80 | 0.80 | 0.74 | 0.87 | 1.01 | 0.93 | Upgrade
|
| Quick Ratio | 2.16 | 2.16 | 2.41 | 2.53 | 2.64 | 2.62 | Upgrade
|
| Current Ratio | 3.34 | 3.34 | 4.00 | 4.15 | 3.87 | 3.95 | Upgrade
|
| Return on Equity (ROE) | 35.18% | 35.18% | 24.88% | 27.12% | 33.83% | 32.30% | Upgrade
|
| Return on Assets (ROA) | 19.85% | 19.85% | 15.16% | 16.62% | 19.93% | 18.52% | Upgrade
|
| Return on Invested Capital (ROIC) | 51.38% | 50.56% | 36.63% | 40.87% | 50.92% | 41.64% | Upgrade
|
| Return on Capital Employed (ROCE) | 37.90% | 37.90% | 28.00% | 31.90% | 36.90% | 34.10% | Upgrade
|
| Earnings Yield | 3.78% | 3.36% | 3.79% | 2.65% | 2.70% | 1.36% | Upgrade
|
| FCF Yield | 4.32% | 3.84% | 5.00% | 2.63% | 2.47% | 1.79% | Upgrade
|
| Dividend Yield | 3.48% | 3.09% | 4.16% | 2.23% | 2.10% | 1.12% | Upgrade
|
| Payout Ratio | 68.76% | 68.75% | 79.37% | 79.15% | 60.01% | 60.11% | Upgrade
|
| Buyback Yield / Dilution | 0.21% | 0.21% | -0.10% | -0.10% | -0.15% | -0.07% | Upgrade
|
| Total Shareholder Return | 3.64% | 3.30% | 4.06% | 2.13% | 1.95% | 1.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.